
Nelesh Govender (also @neleshg.bsky.social)
@neleshg
I study fungal diseases. Prof @witshealthfac. NIHR Research Prof. Hon Prof @MRCcmm @StGeorgesUni @UCTHealthSci. Sabbatical @nicd_sa. MD, micro, epi 🌈
ID: 42234603
https://witsmycology.co.za/ 24-05-2009 16:12:37
2,2K Tweet
1,1K Followers
275 Following


Professor Nelesh Govender (also @neleshg.bsky.social) tells researchers considering applying to the NIHR #GlobalHealthResearchProfessorship: 1️⃣Do it, it can be transformational! 2️⃣Apply at the right time in your career 3️⃣LMIC applicants should brief their institutions carefully More info: nihr.ac.uk/funding/global…



Following his NIHR Global Health Research Professorship Nelesh Govender (also @neleshg.bsky.social) has received more of funding, including an impressive $1.7 million from the Gates Foundation. Prof Govender discusses how his professorship has impacted his career and his research on advanced HIV disease⤵️

We are thrilled to share that we are down to double digits! 99 participants left to reach out recruitment target of 600. Looking forward to contributing meaningful data to help to #EndCryptoDeaths 🦠🏥💯 Nelesh Govender (also @neleshg.bsky.social) Sile Molloy Joe Jarvis Kyla Murphy


The rising tide of fungal diseases. This episode features Sumi Robson Wellcome; Nelesh Govender (also @neleshg.bsky.social) Wits Faculty of Health Sciences Wits University; Carolina Coelho Research at Exeter; Mat Fisher Imperial College London; and Neil Gow University of Exeter. thenakedscientists.com/podcasts/naked…


Join us for our next CME webinar focusing on Cryptococcal Case-Based Discussions. Register here bit.ly/3FIJ5Ql for Thursday and here bit.ly/4569GRU for Tuesday Nelesh Govender (also @neleshg.bsky.social) Ndiviwe Mphothulo


Perspective by George R. Thompson III, MD (George Thompson), and Angel N. Desai, MD, MPH: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge nej.md/4kMyVOd #GlobalHealth






WHO celebrates this step to really get on track to end AIDS by 2030!Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries - News Releases - The Global Fund to Fight AIDS, Tuberculosis and Malaria theglobalfund.org/en/news/2025/2…
